ArticleCureus2026
Hematological Disease Profile in the Tribal Population of Northern Maharashtra Based on Bone Marrow Examination: A Retrospective Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Bone marrow examination (BME), comprising bone marrow aspiration (BMA) and bone marrow biopsy (BMB), remains vital for diagnosing hematological disorders, especially when peripheral blood findings are inconclusive. Data on marrow pathology among India's tribal population are limited. Hence, this study aimed to assess clinical indications, diagnostic utility, and association between peripheral blood smear (PBS) and bone marrow findings in the tribal population of northern Maharashtra. Methodology This retrospective, descriptive study included 60 tribal patients who underwent BMA and BMB between January 2023 and March 2024. After excluding inadequate and normal samples, 39 cases were analyzed. Demographic, clinical, and morphological data were reviewed. Association between PBS and bone marrow findings was tested using the Z-test for proportions (p < 0.05). Results Among 60 tribal patients who underwent BME, 39 (65%) yielded adequate and interpretable findings for analysis. Anemia was the most common indication, observed in 23 (59.0%) patients, including microcytic 11 (28.2%), megaloblastic 9 (23.1%), and dimorphic 3 (7.7%) cases. Bone marrow showed a significantly higher diagnostic yield in microcytic anemia compared with PBS (79.0% vs. 21.0%; p < 0.01). Myelodysplastic syndrome (5, 12.8%) was detected exclusively on marrow (p = 0.002). Myeloproliferative neoplasms (5, 12.8%), plasma cell dyscrasias (4, 10.3%), and immune thrombocytopenic purpura (2, 5.1%) were also identified. Conclusions BME demonstrated superior diagnostic accuracy over peripheral smear, particularly for anemia and myelodysplastic syndromes. Strengthening hematopathology services in tribal regions can facilitate earlier diagnosis and management of reversible hematologic disorders, improving outcomes in underserved populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.